共 50 条
T-cell receptor-δ expression and γδ plus T-cell infiltrates in primary cutaneous γδ T-cell lymphoma and other cutaneous T-cell lymphoproliferative disorders
被引:21
|作者:
Pulitzer, Melissa
[1
]
Geller, Shamir
[2
]
Kumar, Erica
[1
]
Frosina, Denise
[1
]
Moskowitz, Alison
[2
]
Horwitz, Steven
[2
]
Myskowski, Patricia
[2
]
Kheterpal, Meenal
[2
]
Chan, Alexander
[1
]
Dogan, Ahmet
[1
]
Jungbluth, Achim
[1
]
机构:
[1] Mem Sloan Kettering Canc Ctr, Dept Pathol, 1275 York Ave, New York, NY 10021 USA
[2] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA
关键词:
classification;
immunohistochemistry;
immunological techniques;
lymphoproliferative disorders;
T-cell lymphoma;
ALPHA-BETA;
CLASSIFICATION;
PANNICULITIS;
LYMPHOCYTES;
PHENOTYPE;
SPECTRUM;
D O I:
10.1111/his.13671
中图分类号:
Q2 [细胞生物学];
学科分类号:
071009 ;
090102 ;
摘要:
Aims: The diagnosis of cutaneous gamma delta T-cell lymphoma (GDTCL) requires the identification of gamma delta chains of the T-cell receptor (TCR). Our aim in this study was, by using a new monoclonal antibody (mAb) against TCR delta, to evaluate TCR delta expression in formalin-fixed paraffin-embedded (FFPE) skin tissue from TCR gamma+ cutaneous T-cell lymphoma (CTCL), and to assess TCR delta expression within a spectrum of other cutaneous lymphoproliferative disorders (CLPDs). Methods and results: Twelve cases (10 patients) with TCR gamma+ CTCL and 132 additional CLPD cases (127 patients) were examined, including mycosis fungoides (MF) (n- 60), cutaneous GDTCL (n = 15), subcutaneous panniculitis-like T-cell lymphoma (SPTCL) (n = 11), and CD30(+) lymphoproliferative disorder (LPD) (n = 24). Clone H-41 against TCR delta was used on a Leica Bond-3 automated stainer to label FFPE slides. H-41 immunostaining was graded as percentage infiltrate: high (50-100%), moderate (10-49%), and low (0-9%). In TCR gamma+ tumours, 12 of 12 (100%) patients showed TCR delta expression comparable to TCR gamma expression. No (0%) TCR gamma+ cases were negative for TCR delta. In all CLPDs, TCR delta expression was as follows: GDTCL, 16 of 20 cases (14 of 15 patients) high, two moderate, and two low; MF, 0 of 60 cases high, nine moderate, and 51 low; CD30(+) LPD, one of 24 cases high, two moderate, and 21 low; and SPTCL, 0 of 11 cases (0 of 9 patients) high, two moderate, and two low. Three MF-like cases and one SPTCL-like case showed high expression; the remainder showed low expression. Conclusions: mAb H-41 against TCR delta matches TCR gamma in immunostaining FFPE tissues from GDTCL, supporting 11-41 as a replacement for mAb gamma 3.20. TCR delta expression in our study suggests that the true occurrence of gamma delta+ non-GDTCL CTCL/CLPD may be lower than suggested by the recent literature.
引用
收藏
页码:653 / 662
页数:10
相关论文